Backgrounds/Aims: The albumin-bilirubin (ALBI) score has been validated as a predictor of disease-free survival and overall survival in hepatocellular carcinoma (HCC). The purpose of this study was to assess the ALBI score as a risk factor for early recurrence (ER) after curative liver resection in HCC. Methods: Patients who underwent liver resection with curative intent for HCC without previous treatment between January 2004 and December 2014 were included in this retrospective study. The utility of the ALBI score in predicting ER and late recurrence (LR) was evaluated. Results: A total of 465 HCC patients were enrolled; multivariate analysis identified ALBI grade ≥2 (p=0.003) as a risk factor for ER, in addition to hepatitis B virus surface antigen (HBsAg)-positive status (p＜0.001), tumor size ≥3.5cm (p≤0.001), lymph-vascular invasion (p=0.001), and the presence of satellite lesions (p=0.009). In subgroup analysis for ALBI grade 1, Model for End-stage Liver Disease score ＞9 (p=0.046), HBsAg positive status (p=0.004), tumor size ≥3.5 cm (p＜0.001), lymph-vascular invasion (p=0.001), presence of satellite lesions (p=0.002), and poor tumor differentiation (p=0.007) were independent risk factors for ER; however, in subgroup analysis for ALBI grade 2, no significant associations with ER were found. Kaplan-Meier curve analysis showed that long-term survival in HCC with ER was significantly shorter than in patients with LR. Conclusions: The ALBI score was a preoperative risk factor for ER and may be useful in determining appropriate management according to liver function when recurrence develops. (Ann Hepatobiliary Pancreat Surg 2018;22:335-343)
INTRODUCTION
Hepatocellular carcinoma (HCC) is common, and is one of the leading causes of death worldwide. 1 Liver resection is standard treatment for HCC, followed by liver transplantation, but is a major cause of death in long term follow-up due to recurrence, even after liver resection. [2] [3] [4] The overall recurrence rate is reportedly 54% to 63% after HCC treatment. 5, 6 Other studies have shown an early recurrence rate of 38% 7 less than a year after radical hepatectomy, and it is known that tumor stage, presence of microsatellites, microvascular invasion, liver cirrhosis, multinodularity, hepatitis activity, and alpha-fetoprotein (AFP) level are associated with early recurrence. [8] [9] [10] [11] It is very important to determine the risk factors for early recurrence and to diagnose early postoperative recurrence with strict follow-up because transarterial chemoembolization (TACE), radiofrequency ablation (RFA), or reoperation can increase survival duration. 12 The albumin-bilirubin (ALBI) score has been highlighted as a predictor of postoperative hepatic failure and long-term survival after hepatic resection, and is a new tool for the assessment of liver failure and function. 12 According to another study, ALBI grade was associated with significant differences in disease-free survival after hepatectomy for HCC. 13 We hypothesized a relationship between ALBI score and early recurrence (ER). To date, no study has determined whether ALBI grade is associated with recurrence within a year (we defined this as ER). Therefore, this study aimed to investigate the usefulness of ALBI score for relapse within a year. 
MATERIALS AND METHODS

Patients
Diagnosis and definitions
We defined ER as recurrence within a year after curative liver resection for HCC, based on a study by TungPing Poon et al. 12 Diagnosis of HCC was based on histological evidence after surgery. Major liver resection was defined as resection of at least three Couinaud liver segments. 14 In pathologic reports, vascular invasion included gross as well as microscopic invasion of vessels.
Microscopic vascular invasion is defined by tumor within a vascular space lined by endothelium, identified only on microscopy in the capsule or noncapsular fibrous septa, or liver tissue surrounding the tumor. The ALBI score is a validated formula used for rigorous statistical analysis of HCC patients, based on bilirubin and albumin levels. 15 In this study, the ALBI score was calculated using the following formula with preoperative laboratory analysis:
The ALBI score was stratified as grade 1 (-2.60 or less), grade 2 (-2.59 to -1.39), or grade 3 (greater than -1.39).
Follow-up
All patients were followed up at 1 month after liver resection, followed by every 3 months in the first year and every 3-6 months in subsequent years. HBsAg, hepatitis B surface antigen; Anti-HCV, Anti-hepatitis C virus 95% CI: 0.79-0.98) were significant risk factors (Table 3) .
Subgroup analysis by ALBI grade
We performed subgroup analysis by preoperative ALBI grade 1 and 2 after excluding 2 patients of ALBI grade 3 ( Table 5 ).
The Kaplan-Meier curve showed that significantly lower overall survival in ER patients than non-ER patients (Fig. 2) .
DISCUSSION
In this study, the risk factors for ER after curative liver resection in HCC patients were AFP ≥40, preoperative vious studies suggest that intrahepatic metastases are the main cause of early intrahepatic recurrence. 4, 16 In this study, ALBI score was found to be associated with ER, which was not reported in previous studies.
ALBI score has been identified as one of the best indicators of liver function. Most studies have shown that the ALBI score may be a better predictor of liver function than the CP score, MELD score, and ICGR15 and is therefore more useful as a predictor of postoperative hepatic failure. 17 Moreover, several studies have found that ALBI is associated with prognostic factors for disease-free survival and overall survival. 13 Kanda et al. 18 reported that ALBI grade 2 patients were more likely to have shorter disease-specific and disease-free survival after radical gastrectomy, compared with that for ALBI grade 1 patients.
Additionally multivariable analysis identified ALBI grade 2 as an independent prognostic factor for disease-free survival.
We performed subgroup analysis based on the assumption that liver function is associated with ER. Our study has some limitations. First, this study was conducted at a single institution, and the retrospective study design might have resulted in bias. Second, the most common cause of HCC in this study was hepatitis B virus, but HCC in Western countries is associated with other causes such as hepatitis C virus infection. Therefore, more studies are required according to etiological populations.
Despite these limitations, this study showed that ALBI grade was associated with ER after curative liver resection for HCC and could be useful as a preoperative predictor of ER. The ALBI grade can also be used to determine the likelihood of resection or transplantation because liver function can be assessed.
In conclusion, preoperative ALBI grade ≥2 is a preoperative risk factor for ER, along with other well-known factors, and requires more thorough follow-up. ALBI grade may be useful in determining appropriate management according to liver function when recurrence develops.
